A subscription to JoVE is required to view this content. Sign in or start your free trial.

Review Article

The P2X7 Purinergic Receptor Modulates Neuroimmune and Neuronal Signaling in the Pathogenesis of Neuropathic Pain

251 views

⸱

DOI:

10.3791/69940

⸱

March 24th, 2026

 ,  ,  ,  , 

* These authors contributed equally

In This Article

Summary

This article describes the role of the P2X7 receptor in the participation of astrocytes, neurons, and microglia in neuropathic pain (NPP). Targeting the P2X7 receptor could be a molecular target for NPP therapy.

Abstract

Primary and secondary injuries of the nervous system can induce neuropathic pain (NPP), which severely impacts patients' physical and mental health and imposes a significant economic burden on individuals, families, and society. Currently, effective curative treatments remain elusive. Consequently, investigating the molecular basis of NPP's pathological mechanisms is crucial for developing targeted therapies. The ion channel P2X7 purinergic receptor (P2X7R) is widely expressed in the nervous system and plays a vital role in maintaining its functional stability. Accumulating evidence indicates that P2X7R is a pain-related molecule involved in the initiation and progression of NPP. The activation or upregulation of P2X7R contributes to NPP by mediating the activities of immune cells, glial cells, and neurons, regulating intercellular interactions among them, enhancing sensory signal transmission and synaptic plasticity, and ultimately leading to central sensitization. Notably, targeted inhibition of P2X7R activation using specific antagonists (e.g., A438079, A740003, and BBG) exhibits pharmacological analgesic properties. Furthermore, downregulating P2X7R expression in tissues/cells via alternative approaches (such as pharmacological agents, cell therapy, and physical therapy) also demonstrates therapeutic potential against NPP. This review comprehensively discusses the mechanisms by which P2X7R regulates both neuronal and non-neuronal cells in NPP. Given its characteristics, targeting P2X7R expression or antagonizing its activity represents a promising, novel pharmacological strategy for NPP treatment.

Introduction

Neuropathic pain (NPP), a chronic condition resulting from lesions or diseases of the somatosensory nervous system, severely compromises patients' quality of life. It manifests as spontaneous pain (e.g., burning, tingling), hyperalgesia, and allodynia, in which innocuous stimuli such as light touch provoke pain. In addition, it is worth noting that even after the nociceptive stimulation is eliminated, the pain can still exist, which may be related to the unrepaired nerve injury. Pain induced by nerve injury can spread to adjacent areas, and its potential pathophysiology involves peripheral and central sensitization, which involves many factors, including chan....

Access restricted. Please log in or start a trial to view this content.

Review and Perspective

1. NPP

NPP is caused by primary or secondary direct or indirect damage to the central or peripheral nervous system, resulting in dysfunction or transient disorders of the nervous system and sensory information transmission, mainly manifested as spontaneous pain, hyperalgesia, or abnormal pain1. NPP arises from peripheral parts of the nervous system, such as trigeminal neuralgia, post-herpetic neuralgia, peripheral nerve injury, painful polyneuropathy, or radiculopathy. Peripheral sensory information can be transmitted to the center (a key factor in the perception of chronic pain). The increased sensiti....

Access restricted. Please log in or start a trial to view this content.

Conclusions

The mechanism of NPP after nerve injury is complex, which can lead to sensory and motor dysfunction, seriously affect the quality of life of patients, and there is no effective treatment. Therefore, mining the molecular basis of NPP is helpful to the treatment of NPP. Fortunately, ion channel P2X7R has been shown to play a key role in the occurrence and development of NPP. Activation or overexpression of P2X7R can regulate glial cell and macrophage activation, mediate the release of pro-inflammatory cytokines and the inf.......

Access restricted. Please log in or start a trial to view this content.

References

  1. Finnerup, N. B., Kuner, R., Jensen, T. S. Neuropathic pain: From mechanisms to treatment. Physiol Rev. 101 (1), 259-301 (2021).
  2. Xu, Y., Jiang, Z., Chen, X. Mechanisms underlying paclitaxel-induced neuropathic pain: Channels, inflammation and immune regulation....

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Explore More Articles

P2X7 ReceptorNeuroimmune SignalingCentral SensitizationGlial CellsImmune CellsSynaptic PlasticityP2X7 AntagonistsPain Pathogenesis